PBH
NYSE · Pharmaceuticals
Prestige Consumer Healthcare
$54.85
+0.42 (+0.77%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-16.07%
1Y
-16.36%
YTD
-10.41%
Open$54.95
Previous Close$54.43
Day High$55.45
Day Low$54.15
52W High$75.31
52W Low$42.62
Volume—
Avg Volume575.0K
Market Cap2.61B
P/E Ratio13.70
EPS$3.91
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$64.04
Below
SMA 200
$69.15
Below
RSI (14)
68.6
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
10 analysts
Price Target
+42.5% upside
Current
$54.85
$54.85
Target
$78.15
$78.15
$50.25
$78.15 avg
$108.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.06B | 1.07B | 462.83M |
| Net Income | 185.61M | 169.03M | 138.88M |
| Profit Margin | 17.5% | 16.6% | 30.0% |
| EBITDA | 322.21M | 309.72M | 217.92M |
| Free Cash Flow | — | — | 109.94M |
| Rev Growth | -1.2% | -1.2% | +15.0% |
| Debt/Equity | 0.54 | 0.54 | 0.82 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |